Is Intestinal Inflammation Linking Dysbiosis to Gut Barrier Dysfunction During Liver Disease?

Overview

Journal Expert Rev Gastroenterol Hepatol

Specialty Gastroenterology

Date 2015 Jun 20

PMID 26088524

Citations 30

Authors

Katharina Brandl

Bernd Schnabl

Affiliations

Soon will be listed here.

Abstract

Changes in the intestinal microbiota composition contribute to the pathogenesis of many disorders including gastrointestinal and liver diseases. Recent studies have broadened our understanding of the "gut-liver" axis. Dietary changes, other environmental and genetic factors can lead to alterations in the microbiota. Dysbiosis can further disrupt the integrity of the intestinal barrier leading to pathological bacterial translocation and the initiation of an inflammatory response in the liver. In this article, the authors dissect the different steps involved in disease pathogenesis to further refine approaches for the medical management of liver diseases. The authors will specifically discuss the role of dysbiosis in inducing intestinal inflammation and increasing intestinal permeability.

Citing Articles

NLRP3 activation maintains intestinal epithelial barrier and reduces liver injury in alcoholic liver disease mice.

Li S, Wang Y, Xie Z, Wang Y, Feng Z, Xu J Clin Transl Med. 2024; 14(12):e70099.

PMID: 39605303 PMC: 11602754. DOI: 10.1002/ctm2.70099.

Intestinal Insights: The Gut Microbiome's Role in Atherosclerotic Disease: A Narrative Review.

Alexandrescu L, Suceveanu A, Stanigut A, Tofolean D, Axelerad A, Iordache I Microorganisms. 2024; 12(11).

PMID: 39597729 PMC: 11596410. DOI: 10.3390/microorganisms12112341.

The Use of Proton Pump Inhibitors in Patients with Liver Cirrhosis: Real Life Experience.

Eftimie Spitz R, Popa S, Grad S, Dumitrascu D, Ismaiel A, Surdea-Blaga T J Clin Med. 2024; 13(17).

PMID: 39274368 PMC: 11396469. DOI: 10.3390/jcm13175155.

Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship.

Vegda H, Patel B, Girdhar G, Pathan M, Ahmad R, Haque M Cureus. 2024; 16(7):e63775.

PMID: 39100036 PMC: 11297857. DOI: 10.7759/cureus.63775.

isolated from giant panda can attenuate dextran sodium sulfate-induced colitis in mice.

Yu S, Xie J, Guo Q, Yan X, Wang Y, Leng T Front Microbiol. 2024; 15:1361945.

PMID: 38646621 PMC: 11027743. DOI: 10.3389/fmicb.2024.1361945.

References

Kummen M, Schrumpf E, Boberg K . Liver abnormalities in bowel diseases. Best Pract Res Clin Gastroenterol. 2013; 27(4):531-42. DOI: 10.1016/j.bpg.2013.06.013. View

Blair S, Kane S, Clayburgh D, Turner J . Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest. 2006; 86(2):191-201. DOI: 10.1038/labinvest.3700373. View

van der Sluis M, de Koning B, de Bruijn A, Velcich A, Meijerink J, van Goudoever J . Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006; 131(1):117-29. DOI: 10.1053/j.gastro.2006.04.020. View

Wiest R, Lawson M, Geuking M . Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2013; 60(1):197-209. DOI: 10.1016/j.jhep.2013.07.044. View

Leclercq S, Matamoros S, Cani P, Neyrinck A, Jamar F, Starkel P . Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014; 111(42):E4485-93. PMC: 4210345. DOI: 10.1073/pnas.1415174111. View

Tuomisto S, Pessi T, Collin P, Vuento R, Aittoniemi J, Karhunen P . Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics. BMC Gastroenterol. 2014; 14:40. PMC: 3996058. DOI: 10.1186/1471-230X-14-40. View

Mazagova M, Wang L, Anfora A, Wissmueller M, Lesley S, Miyamoto Y . Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice. FASEB J. 2014; 29(3):1043-55. PMC: 4422368. DOI: 10.1096/fj.14-259515. View

Zenewicz L, Yancopoulos G, Valenzuela D, Murphy A, Stevens S, Flavell R . Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008; 29(6):947-57. PMC: 3269819. DOI: 10.1016/j.immuni.2008.11.003. View

Grivennikov S, Karin E, Terzic J, Mucida D, Yu G, Vallabhapurapu S . IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009; 15(2):103-13. PMC: 2667107. DOI: 10.1016/j.ccr.2009.01.001. View

10.

Kirpich I, Solovieva N, Leikhter S, Shidakova N, Lebedeva O, Sidorov P . Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol. 2008; 42(8):675-82. PMC: 2630703. DOI: 10.1016/j.alcohol.2008.08.006. View

11.

Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal W, Strowig T . Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482(7384):179-85. PMC: 3276682. DOI: 10.1038/nature10809. View

12.

Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W . Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75(2):263-74. DOI: 10.1016/0092-8674(93)80068-p. View

13.

Ding S, Chi M, Scull B, Rigby R, Schwerbrock N, Magness S . High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One. 2010; 5(8):e12191. PMC: 2922379. DOI: 10.1371/journal.pone.0012191. View

14.

Taniguchi K, Wu L, Grivennikov S, de Jong P, Lian I, Yu F . A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature. 2015; 519(7541):57-62. PMC: 4447318. DOI: 10.1038/nature14228. View

15.

Reunanen J, Kainulainen V, Huuskonen L, Ottman N, Belzer C, Huhtinen H . Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol. 2015; 81(11):3655-62. PMC: 4421065. DOI: 10.1128/AEM.04050-14. View

16.

George M, Asmuth D . Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?. Curr Opin Infect Dis. 2014; 27(3):275-81. DOI: 10.1097/QCO.0000000000000059. View

17.

Rojas-Feria M, Castro M, Suarez E, Ampuero J, Romero-Gomez M . Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. World J Gastroenterol. 2013; 19(42):7327-40. PMC: 3831215. DOI: 10.3748/wjg.v19.i42.7327. View

18.

Brandl K, Plitas G, Schnabl B, DeMatteo R, Pamer E . MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med. 2007; 204(8):1891-900. PMC: 2118673. DOI: 10.1084/jem.20070563. View

19.

Hammerich L, Tacke F . Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clin Exp Gastroenterol. 2014; 7:297-306. PMC: 4158890. DOI: 10.2147/CEG.S43737. View

20.

Guarner C, Gonzalez-Navajas J, Sanchez E, Soriando G, Frances R, Chiva M . The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology. 2006; 44(3):633-9. DOI: 10.1002/hep.21286. View